Phase II Study of Preoperative FOLFIRINOX Versus Gemcitabine/Nab-Paclitaxel in Patients With Resectable Pancreatic Cancer

التفاصيل البيبلوغرافية
العنوان: Phase II Study of Preoperative FOLFIRINOX Versus Gemcitabine/Nab-Paclitaxel in Patients With Resectable Pancreatic Cancer
المساهمون: David Patrick Ryan, MD, Principal Investigator
المصدر: Phase II Study of Preoperative FOLFIRINOX Versus Gemcitabine/Nab-Paclitaxel in Patients With Resectable Pancreatic Cancer
الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT02243007Test
قاعدة البيانات: ClinicalTrials.gov